Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Nuclear condensates of YAP fusion proteins as a critical driver for ependymoma

ABSTRACT: To further determine chromatin conformation and long-range enhancer/promoter interactions altered by YAP-M, we performed a whole-genome chromatin capture assay using Hi-ChIP.

ORGANISM(S): Mus musculus

PROVIDER: GSE207801 | GEO | 2022/10/27

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Nuclear condensates of YAP fusion proteins as a critical driver for ependymoma

Project description:Nuclear condensates of YAP fusion proteins as a critical driver for ependymoma

| PRJNA857085 | ENA

Phase separation of YAP fusion proteins drives supratentorial ependymoma I

Project description:HIPPO-YAP/TAZ signaling has been implicated in supratentorial ependymoma formation from neural progenitor cells (NPC) in the brain, however, the underlying mechanisms to trigger the neural progenitor cell transformation remains elusive. Here, we uncover that patient-derived tumorigenic YAP-fusion proteins (YAP-MAMLD1 and C11ORF95-YAP) promote ependymoma tumorigenesis through forming liquid-liquid phase-separated condensates. Intrinsically disordered regions (IDR) in the fusion proteins promote oligomerization of YAP-transcriptional co-activators and self-assembly of nuclear puncta-like membrane-less organelles. Phase separation of YAP-fusion proteins further facilitates the compartmentalization of transcriptional coactivators, BRD4 and MED1, resulting in pervasive enhancer landscape changes and exclusion of transcriptional repressors such as PRC2 complexes. YAP-fusion proteins-induced nuclear puncta recruit RNA polymerase II to promote transcriptional bursting of multiple oncogenic pathways. Moreover, we show that IDR-mediated phase separation is necessary for YAP-fusion protein-induced tumor formation. Distinct YAP fusion-proteins identified in other human tumors also encompass IDR features. Together, our data suggest that IDR-mediated phase separation is an integral component of YAP-fusion protein-induced tumorigenesis and might serve as a therapeutic target in supratentorial ependymoma.

2022-10-27 | GSE181867 | GEO

Phase separation of YAP fusion proteins drives supratentorial ependymoma (methyl-seq)

2022-10-27 | GSE206926 | GEO

Phase separation of YAP fusion proteins drives supratentorial ependymoma

Project description:Phase separation of YAP fusion proteins drives supratentorial ependymoma

| PRJNA854642 | ENA

Phase separation of YAP fusion proteins drives supratentorial ependymoma I

Project description:Phase separation of YAP fusion proteins drives supratentorial ependymoma I

| PRJNA753777 | ENA

Phase separation of YAP fusion proteins drives supratentorial ependymoma (methyl-seq)

Project description:Phase separation of YAP fusion proteins drives supratentorial ependymoma (methyl-seq)

| PRJNA852700 | ENA

Phase separation of YAP fusion proteins drives supratentorial ependymoma

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-10-27 | GSE207293 | GEO

The TAZ-CAMTA1 and YAP-TFE3 fusion proteins modulate the basal TAZ/YAP transcriptional program by recruiting the Ada2a-containing histone acetyltransferase complex [atacseq]

Project description:The WWTR1(TAZ)-CAMTA1 and YAP1-TFE3 gene fusions are disease defining gene alterations for epithelioid hemangioendothelioma, a vascular cancer. The resultant fusion proteins fuse the C terminus of CAMTA1 and TFE3 in frame to the N terminus of TAZ and YAP, respectively. An unbiased BioID-mass spectrometry/RNAi screen identified YEATS2 and ZZZ3 as components of the Ada2a-containing histone acetyltransferase complex and key interactors of both TAZ-CAMTA1 and YAP-TFE3. An integrative NGS approach including RNA-Seq, ChIP-Seq, and ATAC-Seq showed TAZ-CAMTA1 and YAP-TFE3 transcriptional programs overlap with TAZ and YAP but also drive expression of a novel transcriptome. The altered transcriptional program of the fusion proteins owing to altered DNA binding as well as shifts in the chromatin landscape.

2020-12-01 | GSE152733 | GEO

The TAZ-CAMTA1 and YAP-TFE3 fusion proteins modulate the basal TAZ/YAP transcriptional program by recruiting the Ada2a-containing histone acetyltransferase complex [rnaseq_sw872]

2020-12-01 | GSE152737 | GEO

The TAZ-CAMTA1 and YAP-TFE3 fusion proteins modulate the basal TAZ/YAP transcriptional program by recruiting the Ada2a-containing histone acetyltransferase complex [chipseq]

2020-12-01 | GSE152778 | GEO